Poland· PL-100432512

Capsagamma

A capsaicin and similar agents product containing capsici extractum spissum normatum, registered in Poland by Woerwag Pharma GmbH & Co. KG. The same ATC class is registered in 6 of our 19 countries.

ATC M02AB

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCapsagammaATCM02ABREGISTER NO.PL-100432512PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Capsici extractum spissum normatum is registered in 6 of 19 countries.

Countries holding a registration under ATC M02AB (capsaicin and similar agents), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose

Capsici extractum spissum normatum · ATC M02AB

6 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Ireland
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Capsici extractum spissum normatum
Manufacturer
Woerwag Pharma GmbH & Co. KG
Country
Poland (PL)
ATC code
M02AB
ATC class
Capsaicin and similar agents
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991425937
  • gtin
    05909991425944

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Capsici extractum spissum normatum in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All capsici extractum spissum normatum products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Germany · Prick-Testlösung Paprika
  • Greece · Salonpas Hot

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fdd759f6-925c-4918-aed7-9b9dc563b697
GET /v1/drugs/fdd759f6-925c-4918-aed7-9b9dc563b697?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Krem",
  "source": "urpl",
  "strength": "53 mg kapsaicynoidów w przeliczeniu na kapsaicynę/100 g",
  "packaging": "05909991425937 ¦ OTC ¦ 135658\n1 tuba 40 g\n05909991425944 ¦ OTC ¦ 135659\n1 tuba 100 g",
  "substance": "Capsici extractum spissum normatum [(DER pierwotny 2,8 - 4,9:1); 2,2% Kapsaicynoidów w przeliczeniu na kapsaicynę; rozpuszczalnik ekstrakcyjny: etanol 80% (v/v); substancja pomocnicza: glukoza ciekła o składzi: wyciag pierwotny - 42,1% - 98,6%, substancja pomocnicza - 57,9% - 1,4%] - 2,409 g/100 g",
  "common_name": "Capsici extractum spissum normatum",
  "pl_product_id": "100432512",
  "pozwolenie_nr": "26128",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about capsici extractum spissum normatum.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.